Biotage
announces the launch of ACI™ (Accelerated Chromatographic
Isolation), a new advance converting simple flash purification into a
faster and more economical way to isolate pure compounds.
Uppsala,
Sweden (July 10, 2014) -- Biotage
(STO: BIOT), a leading global supplier of solutions and technology
for analytical, medicinal and peptide chemistry, announces the launch
of ACI™ (Accelerated Chromatographic Isolation), a new advance
converting simple flash purification into a faster and more
economical way to isolate pure compounds.
Biotage
believes that ACI™ will radically improve the efficiency of the
laboratory, embracing the latest developments in purification
technology to guide chemists towards improved chromatography. With
running costs a concern in most laboratories, ACI™ will efficiently
move users to the end-point even faster. Traditional purification
taking more than 15 minutes is reduced to 5 minutes; a 250 mg scale
laboratory scale experiment can now be purified in less than 3
minutes on a 10 g column with an ACI™ enabled Biotage Isolera™
flash purification system.
"This
is a very exciting and pivotal development, the speed enhancements
are akin to the impact felt when microwaves first hit the scene.
There is nothing out there that comes close to this system. Chemists
will now have freedom to work on other things while they let their
ACI™ system do the purification. It is fully automated, reliable
and lightning fast, we can completely purify 250 mg of sample in less
than 3 minutes, this is quicker than most people take to run the TLC"
says Dr Sunil Rana, Global Product Manager, Biotage.
Biotage
Isolera™ systems already recommend cartridges based on the sample
size and programmed TLC data; they work out the best solvent gradient
based on compound, and provide real time indication of eluting
compounds, using UV, ELSD or Mass Detection. They subtract signal
baselines automatically, so chemists can be confident that the
correct fractions are collected.
ACI™
radically improves this, working seamlessly with the Biotage Isolera™
system, the simple wizard quickly guides chemists through the system,
beneficial for new users or those whose expertise or priorities lie
in synthesis rather than purification. Existing Biotage Isolera
systems can be upgraded to ACI™ systems, and ACI™ will come as
standard on all new production systems.
For
further information visit http://www.biotage.com
or call:
In
Europe: +46 18 56 57 10
In
North America: (Toll Free) 1 800 446 4752
In
Japan: +81 422 28 1233
Other
areas, please call: +46 18 56 57 10
-Ends-
For
further press information from Biotage please contact:
James
Churchill
Marketing
Communications
Biotage
GB Limited
Distribution
Way
Dyffryn
Business Park
Ystrad
Mynach
Hengoed,
Wales CF82 7TS
United
Kingdom
Tel:
+44 (0)1443 811 849
Mobile:
+44(0)7875484778
E-Mail:
james.churchill@biotage.com
About
Biotage
Biotage
offers solutions, knowledge and experience in the areas of analytical
and medicinal chemistry. Customers include the world's top
pharmaceutical and biotechnology companies, as well as leading
academic institutes. The company is headquartered in Uppsala, Sweden,
with offices in China, Japan, the United Kingdom, the United States
and a worldwide network of distributors. Biotage has 290 employees
with sales of 444.6 MSEK in 2013. Biotage is listed on the NASDAQ OMX
Nordic Stock Exchange. Website: http://www.biotage.com.
